These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28061828)

  • 1. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
    Shu D; Xu F; Su Z; Zhang J; Chen C; Zhang J; Ding X; Lv Y; Lin H; Huang P
    BMC Nephrol; 2017 Jan; 18(1):11. PubMed ID: 28061828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    Kawai Y; Masutani K; Torisu K; Katafuchi R; Tanaka S; Tsuchimoto A; Mitsuiki K; Tsuruya K; Kitazono T
    PLoS One; 2018; 13(5):e0196655. PubMed ID: 29795559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.
    Feehally J; Coppo R; Troyanov S; Bellur SS; Cattran D; Cook T; Roberts IS; Verhave JC; Camilla R; Vergano L; Egido J; Wiecek A; Karkoszka H; Tesar V; Maixnerova D; Ots-Rosenberg M; Quaglia M; Rollino C; Magistroni R; Cusinato S; Cravero R; Peruzzi L; Lundberg S; Gesualdo L; Cancarini G; Feriozzi S; Ferrario F;
    Nephron; 2016; 132(1):15-24. PubMed ID: 26586175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y; Wang Z; Guo W; Zhu L; Zhou X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2024 Jul; 39(8):1279-1287. PubMed ID: 38178632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
    Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
    Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.